Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Issues a 'Call to Action' for Patient Videos on Therapy Cap

Jan 26, 2018/News

APTA launched a new call for grassroots advocacy—this time through videos of patients affected by the hard cap. Following is the email sent to all members that contains instructions for participating in the effort. Deadline for videos is February 2, 5:00 pm ET.

The Women Who Shaped Our Lives

Mar 16, 2022/Perspective

We asked seven APTA members about the women who inspired them in their chosen profession, and how they in turn hope to impact the future of physical therapy. Here's what they had to say.

ICD-10: A Primer for PTs

Oct 1, 2015/Column

The new code sets offer greater specificity in identifying health conditions.

Empowering Women in the Profession

Nov 1, 2020/Feature

What's holding women back in a field they numerically dominate? A look at causes, needs, approaches, and the path forward.

DEI Discussions: Pathways to Leadership

Oct 30, 2020/Podcast

In this installment, we focus on pathways to leadership.

CMS Final 2021 Fee Schedule Presses On With Cut

Dec 1, 2020/Review

The final rule highlights the need for legislative action to give CMS more latitude in budgets and telehealth.

Fee Schedule Advocacy, Part II: Get Ready, Congress

Sep 24, 2021/News

On the heels of APTA's successful grassroots effort aimed at CMS, we're focusing attention on Capitol Hill.

Proposed 2022 Fee Schedule: More Cuts, PTA Differential, Telehealth Obstacles

Jul 16, 2021/Review

The proposal contains few surprises, setting the stage for intensified advocacy efforts directed at CMS and Capitol Hill.

Plugging Into Social Media

Dec 1, 2016/Feature

Social networking is an opportunity for PTs and PTAs to engage in creativity, innovation, and collaboration.

APTA Advocacy Win: Defense Dept. to Roll Out System-Wide Direct Access to PTs

Jan 26, 2024/News

A new report from DOD says that positioning PTs as primary care providers for neuromusculoskeletal conditions is "entirely feasible."